首页 | 本学科首页   官方微博 | 高级检索  
   检索      


A nationwide population-based skin cancer screening in Germany: Proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009)
Authors:Alan C Geller  Rüdiger Greinert  Craig Sinclair  Martin A Weinstock  Joanne Aitken  Mathieu Boniol  Marcus Capellaro  Jean-Francois Doré  Mark Elwood  Suzanne W Fletcher  Richard Gallagher  Sara Gandini  Allan C Halpern  Alexander Katalinic  Robin Lucas  Ashfag A Marghoob  Sandra Nolte  Joachim Schüz  Margaret A Tucker  Beate Volkmer  Eckhard Breitbart
Institution:1. Division of Public Health Practice, Harvard School of Public Health, Boston University School of Medicine, Boston, USA;2. Elbe Klinikum Buxtehude, Centre of Dermatology, Am Krankenhaus 1, 21614 Buxtehude, Germany;3. EUROSKIN e.V., Elbe Klinikum Buxtehude, Am Krankenhaus 1, 21614 Buxtehude, Germany;4. Cancer Prevention Centre, Cancer Council Victoria, 100 Drummond St., Carlton., VIC, 3053 Australia;5. World Health Organization, Collaborative Centre for UV Radiation, USA;6. Skin Cancer Committee, Cancer Council Australia, 1 Rathdowne Street, Carlton, Victoria 3053, Australia;7. Brown University, Dermatoepidemiology Unit, V A Medical Center – 111D, 830 Chalkstone Avenue, Providence, RI 02908, USA;8. Institute for Cancer Epidemiology e.V., University Lübeck, Department of Registration of the Cancer Registry Schleswig-Holstein, Ratzeburger Allee 160, Haus 50, 23538 Lübeck, Germany;9. Director Cancer Registries & Scientific Consultant, Epidemiology, Cancer Council Queensland, 553 Gregory Terrace, Fortitude Valley, Queensland 4006, Australia;10. International Prevention Research Institute iPRI, 95 cours Lafayette, 69006 Lyon, France;11. Association of Dermatological Prevention (ADP), Cremon 11, 20457 Hamburg, Germany;12. INSERM U590, Centre Leon Berard, 28, Rue Laennec, 69373 Lyon Cedex 08, France;13. International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France;14. Family and Community Oncology, BC Cancer Agency, 686 West Broadway # 801 Vancouver BC, V5Z 1G1, Canada;15. Population Medicine, Harvard Medical School, 208 Boulder Bluff, Chapel Hill, NC 27516, USA;p. Cancer Control Research BC Cancer Agency, School of Population and Public Health, University of British Columbia, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada;q. Instituto Europeo di Oncologia, Division of Epidemiology and Biostatics, Via Ramusio, 1-20141 Milano, Italy;r. Memorial Sloan Kettering Cancer Center, Dermatology Service and Department of Epidemiology and Biostatistics, 1275 York Avenue, New York, NY 10065, USA;s. National Centre for Epidemiology and Population Health (NCEPH), The Australian National University, Canberra 0200, Australia;t. Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, 2100 Copenhagen, Denmark;u. National Cancer Institute, Human Genetics Program, Genetic Epidemiology Branch, 6120 Executive Blvd Rm Plaza South 7122, MSC 7236, Bethesda, MD 20892-7236, USA;1. Section of Molecular Urooncology, University of Heidelberg, Medical Faculty Heidelberg, D-69120 Heidelberg, Germany;2. Department of Urology, University of Heidelberg, Medical Faculty Heidelberg, D-69120 Heidelberg, Germany;1. Islamic Azad University, Tehran Medical Branch, Tehran, Iran;2. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran;3. Tehran Positive Club, Tehran, Iran;4. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran;5. Health and Treatment Office of Iranian Prisons Organization, Tehran, Iran;1. Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA;2. Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA;3. Divisions of Cancer Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, VIC, Australia;1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA;2. Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK;3. University of Pittsburgh Graduate School of Public Health;1. 5824 Edson Lane, North Bethesda, MD 20852, USA;1. Hebei Advanced Thin Film Laboratory, Department of Physics, Hebei Normal University, Shijiazhuang City 050024, People’s Republic of China;2. School of Science, Hebei University of Engineering, Handan City 050038, People’s Republic of China;3. Department of Physics and Electronic Science, Liupanshui Normal University, Liupanshui City 553004, People’s Republic of China
Abstract:Skin cancer incidence is increasing worldwide in white populations and mortality rates have not declined throughout most of the world. An extraordinarily high proportion of at-risk individuals have yet to be screened for melanoma but guidelines from esteemed bodies do not currently endorse population-based screening. Evidence for the effectiveness of skin cancer screening is imperative. To this end, scientists in Germany have launched a nationwide skin cancer screening campaign. Herein, we review pilot screening data from Schleswig-Holstein, discuss the launch of the major new national initiative, review issues related to evaluation of that program, and propose seven recommendations from the International Task Force on Skin Cancer Screening and Prevention that was held in Hamburg, Germany, on September 24 and 25, 2009.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号